Medical Brands (Amsterdam) and Decas Botanical Synergies (Carver, MA) have earned EU medical device status for their Cranberry-Active Bladder Capsules, intended to treat or prevent urinary tract infections (UTIs).
Medical Brands (Amsterdam) and Decas Botanical Synergies (Carver, MA) have earned EU medical device status for their Cranberry-Active Bladder Capsules, intended to treat or prevent urinary tract infections (UTIs).
The European Food Safety Authority (EFSA; Parma, Italy) recently rejected a health claim for cranberries and defense against bacterial pathogens. That rejection, soon to enter into law, can only help the market success of Cranberry-Active Bladder Capsules.
Antibiotics still remain a viable market alternative for UTI health, but published science indicates that their use can lead to the body’s increased resistance of other antibiotics.
“As a registered Class IIa medical device, Cranberry-Active is the only cranberry-based product in the European Economic Area and recognized countries that can be freely marketed with a medical claim for treating and preventing urinary tract infections,” said the two companies in a joint press release.
Medical Brands and Decas will present an information seminar on their product at Vitafoods Europe in Geneva later this month (Tuesday, May 22, 2pm).
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.